HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The therapeutic potentials of apelin in obesity-associated diseases.

Abstract
Apelin, a peptide with several active isoforms ranging from 36 to 12 amino acids and its receptor APJ, a G-protein-coupled receptor, are widely distributed. However, apelin has emerged as an adipokine more than fifteen years ago, integrating the field of inter-organs interactions. The apelin/APJ system plays important roles in several physiological functions both in rodent and humans such as fluid homeostasis, cardiovascular physiology, angiogenesis, energy metabolism. Thus the apelin/APJ system has generated great interest as a potential therapeutic target in different pathologies. The present review will consider the effects of apelin in metabolic diseases such as obesity and diabetes with a focus on diabetic cardiomyopathy among the complications associated with diabetes and APJ agonists or antagonists of interest in these diseases.
AuthorsI Castan-Laurell, C Dray, P Valet
JournalMolecular and cellular endocrinology (Mol Cell Endocrinol) Vol. 529 Pg. 111278 (06 01 2021) ISSN: 1872-8057 [Electronic] Ireland
PMID33838166 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2021 Elsevier B.V. All rights reserved.
Chemical References
  • APLN protein, human
  • APLNR protein, human
  • Anti-Obesity Agents
  • Apelin
  • Apelin Receptors
  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Metformin
Topics
  • Animals
  • Anti-Obesity Agents (therapeutic use)
  • Apelin (genetics, metabolism)
  • Apelin Receptors (genetics, metabolism, therapeutic use)
  • Diabetes Mellitus, Type 2 (drug therapy, genetics, metabolism, pathology)
  • Diabetic Cardiomyopathies (drug therapy, genetics, metabolism, pathology)
  • Dipeptidyl-Peptidase IV Inhibitors (therapeutic use)
  • Energy Metabolism (drug effects, genetics)
  • Gene Expression Regulation
  • Homeostasis (drug effects, genetics)
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Metformin (therapeutic use)
  • Obesity (drug therapy, genetics, metabolism, pathology)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: